Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
A boost in protection is needed to offset the persistent disparities in the toll of COVID between racial and ethnic groups.
People at lower risk may not need an updated booster, but without a CDC recommendation, insurance companies wouldn’t have to cover it.
People ages 6 months and older are eligible for new Moderna and Pfizer-BioNTech boosters targeting XBB.1.5 omicron variant.
People 65 and older and immunocompromised people can get a second bivalent booster; most unvaccinated people now need only one initial shot.
Older people, immunocompromised people and those with underlying health conditions can benefit most from additional shots.
Updated boosters could go to the “worried well” who have good insurance rather than to those at highest risk.
Randall N. Hyer, MD, PhD, will continue Blumberg Institute’s hepatitis B and liver cancer research in his new role as president.
NIAID is preparing for the possibility of future variants evading protection against currently available COVID-19 vaccines.
An NIH-sponsored study assessed boosters for adults fully vaccinated with any authorized or approved COVID-19 vaccine.
Natural immunity and vaccine responses may be weaker in people with immune suppression, so they should get their second dose promptly.
A slow vaccine rollout and the emergence of new coronavirus mutations threaten progress in reducing new cases and death.
The technology used in COVID-19 vaccines may also be used to prevent other viral infections and to treat cancer and multiple sclerosis.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.